| A Study of GC203 TIL in Advanced Gynecologic Tumors (10hospital) (NCT05468307) | Shanghai Juncell Therapeutics | 2022-03-10 |
| A Study of GC101 TIL in Advanced Breast Cancer (10hospital) (NCT05142475) | Shanghai Juncell Therapeutics | 2021-11-19 |
| Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC (NCT05420922) | Tongji Hospital | 2021-11-01 |
| A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) (NCT05098171) | Shanghai Juncell Therapeutics | 2021-09-26 |
| A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) (NCT05098197) | Shanghai Juncell Therapeutics | 2021-09-26 |
| A Study of GC101 TIL in Advanced Melanoma (10hospital) (NCT05098184) | Shanghai Juncell Therapeutics | 2021-09-26 |
| Serum MicroRNAs 223 and 146a in Allergic Rhinitis Patients as Biomarkers for Efficacy of Sublingual Immunotherapy (NCT04813380) | Zagazig University | 2021-07-27 |
| TIL and Anti-PD1 in Metastatic Melanoma (NCT03638375) | Leiden University | 2018-07-31 |
| Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis (NCT03388866) | Casa Espirita Terra de Ismael | 2018-05-02 |
| Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma (NCT02765243) | Zhujiang Hospital | 2016-01-01 |
| Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma (NCT02406183) | Radiotherapie | 2015-03-01 |
| Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma (NCT02169609) | Fundació Sant Joan de Déu | 2014-11-26 |
| Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (NCT01863108) | University Hospital, Grenoble | 2013-06-01 |
| Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children (NCT01291381) | Beijing Tongren Hospital | 2009-02-01 |
| Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy (NCT01486498) | Aalborg University | 2005-11-01 |
| SCH708980 With and Without AmBisome for Visceral Leishmaniasis (NCT01437020) | National Institute of Allergy and Infectious Diseases (NIAID) | |